3-benzyloxycarbonylamino-2,3-dihydro-1,5-benzothiazepin-4(5H)-one → 3-Amino-2,3-dihydro-1,5-benzothiazepin-4(5H)-one

HRID 1719105Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1719105
C(OC([NH:11][CH:12]1[C:18](=[O:19])[NH:17][C:16]2[CH:20]=[CH:21][CH:22]=[CH:23][C:15]=2[S:14][CH2:13]1)=O)C1C=CC=CC=1>CO.[C].[Pd]>[NH2:11][CH:12]1[C:18](=[O:19])[NH:17][C:16]2[CH:20]=[CH:21][CH:22]=[CH:23][C:15]=2[S:14][CH2:13]1

Komponenten

4

Edukt 1

HCID 133751053-benzyloxycarbonylamino-2,3-dihydro-1,5-benzothiazepin-4(5H)-one

Produkt 1

HCID 3573343-Amino-2,3-dihydro-1,5-benzothiazepin-4(5H)-one

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 178418390HCID 178418390, VerbindungKatalysatorHCID 887MethanolLösungsmittel

Versuchsvorschrift

1.0 g of 3-benzyloxycarbonylamino-2,3-dihydro-1,5-benzothiazepin-4(5H)-one was dissolved in 20 ml of methanol and then hydrogenated at atmospheric pressure in the presence of 50 mg of 5% palladium-carbon. Thus, there was obtained the desired compound, or 3-amino-2,3-dihydro-1,5-benzothiazepin-4(5H)-one.

Quellen und Nachweise

ORD-Eintrag
ord-ca91a323ecab4a5f8a1d788457d863e8
Quelldatensatz
uspto-grants-1985_09
Patentnummer
US04539151

Notizen zur Reaktion

Wird geladen…